Showing 1 - 7 results of 7 for search 'Fabrizio Facchinetti', query time: 0.03s Refine Results
  1. 1
    Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease

    Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease by Fabrizio Facchinetti, Maurizio Civelli, Dave Singh, Alberto Papi, Aida Emirova, Mirco Govoni

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases

    Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases by Hoang Oanh Nguyen, Laura Tiberio, Fabrizio Facchinetti, Giulia Ripari, Valentina Violi, Gino Villetti, Valentina Salvi, Daniela Bosisio

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

    Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder by Cataldo Martucci, Andrew Dennis Allen, Nadia Moretto, Valentina Bagnacani, Alessandro Fioni, Riccardo Patacchini, Maurizio Civelli, Gino Villetti, Fabrizio Facchinetti

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

    CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder by Cataldo Martucci, Andrew Dennis Allen, Nadia Moretto, Valentina Bagnacani, Alessandro Fioni, Riccardo Patacchini, Maurizio Civelli, Gino Villetti, Fabrizio Facchinetti

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Phosphodiesterase 4 inhibitors attenuate virus‐induced activation of eosinophils from asthmatics without affecting virus binding

    Phosphodiesterase 4 inhibitors attenuate virus‐induced activation of eosinophils from asthmatics without affecting virus binding by Yanaika Shari Sabogal Piñeros, Tamara Dekker, Barbara Smids, Christof J. Majoor, Lara Ravanetti, Gino Villetti, Maurizio Civelli, Fabrizio Facchinetti, René Lutter

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    The benefits, limitations and opportunities of preclinical models for neonatal drug development

    The benefits, limitations and opportunities of preclinical models for neonatal drug development by Sarah Campion, Amy Inselman, Belinda Hayes, Costanza Casiraghi, David Joseph, Fabrizio Facchinetti, Fabrizio Salomone, Georg Schmitt, Julia Hui, Karen Davis-Bruno, Karen Van Malderen, LaRonda Morford, Luc De Schaepdrijver, Lutz Wiesner, Stephanie Kourula, Suna Seo, Susan Laffan, Vijay Urmaliya, Connie Chen

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Rho-Kinase 1/2 Inhibition Prevents Transforming Growth Factor-β-Induced Effects on Pulmonary Remodeling and Repair

    Rho-Kinase 1/2 Inhibition Prevents Transforming Growth Factor-β-Induced Effects on Pulmonary Remodeling and Repair by Xinhui Wu, Xinhui Wu, Vicky Verschut, Manon E. Woest, Manon E. Woest, Manon E. Woest, John-P, John-P, Ana Matias, Ana Matias, Gino Villetti, Alessandro Accetta, Fabrizio Facchinetti, Reinoud Gosens, Reinoud Gosens, Loes E. M. Kistemaker, Loes E. M. Kistemaker, Loes E. M. Kistemaker

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: